V Brito-Babapulle
Overview
Explore the profile of V Brito-Babapulle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juliusson G, Gahrton G, Oscier D, Fitchett M, Ross F, Brito-Babapulle V, et al.
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:21-5.
PMID: 27463475
Chromosome analysis on CLL-cells from 649 patients revealed clonal changes in 311 cases (48%). The most common abnormalities were trisomy 12 (n = 112), and structural changes on the long...
2.
Del Giudice I, Osuji N, Dexter T, Brito-Babapulle V, Parry-Jones N, Chiaretti S, et al.
Leukemia
. 2009 Jul;
23(11):2160-7.
PMID: 19641528
No abstract available.
3.
Catovsky D, Richards S, Matutes E, Oscier D, Dyer M, Bezares R, et al.
Lancet
. 2007 Jul;
370(9583):230-239.
PMID: 17658394
Background: Previous studies of patients with chronic lymphocytic leukaemia reported high response rates to fludarabine combined with cyclophosphamide. We aimed to establish whether this treatment combination provided greater survival benefit...
4.
Parry-Jones N, Matutes E, Morilla R, Brito-Babapulle V, Wotherspoon A, Swansbury G, et al.
Br J Haematol
. 2007 Mar;
137(2):117-24.
PMID: 17391491
Mantle cell lymphoma (MCL), characterised by t(11;14)(q13;q32), has a poor prognosis. Many cases have additional cytogenetic abnormalities, and often have a complex karyotype. Fluorescence in situ hybridisation (FISH) was used...
5.
Del Giudice I, Davis Z, Matutes E, Osuji N, Parry-Jones N, Morilla A, et al.
Leukemia
. 2006 Apr;
20(7):1231-7.
PMID: 16642047
B-prolymphocytic leukemia (B-PLL) is a rare disease with poor prognosis. To further characterize the biological features of this disease, we analyzed immunoglobulin heavy chain (IgVH) mutations, ZAP-70 and CD38 in...
6.
Carter A, Lin K, Sherrington P, Atherton M, Pearson K, Douglas A, et al.
Leukemia
. 2006 Jan;
20(4):737-40.
PMID: 16437137
No abstract available.
7.
Matutes E, Parry-Jones N, Brito-Babapulle V, Wotherspoon A, Morilla R, Atkinson S, et al.
Leuk Lymphoma
. 2004 Sep;
45(10):2007-15.
PMID: 15370245
Mantle-cell lymphoma (MCL) is a B-cell malignancy with distinct molecular genetics and pathological features. Peripheral blood involvement has been reported with variable frequency, but information on the natural history of...
8.
Tuset E, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D
Leuk Lymphoma
. 2002 Mar;
42(6):1379-83.
PMID: 11911422
T-cell prolymphocytic leukaemia (T-PLL) is an aggressive disease often resistant to conventional chemotherapy. Long lasting remissions with the monoclonal antibody CAMPATH-1H (anti-CD52) have been documented. We describe two unusual T-PLL...
9.
Dearden C, Matutes E, Cazin B, Tjonnfjord G, Parreira A, Nomdedeu B, et al.
Blood
. 2001 Sep;
98(6):1721-6.
PMID: 11535503
T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-resistant malignancy with a median survival of 7.5 months. Preliminary results indicated a high remission induction rate with the human CD52 antibody, CAMPATH-1H. This...
10.
Brito-Babapulle V, Baou M, Matutes E, Morilla R, Atkinson S, Catovsky D
Br J Haematol
. 2001 Sep;
114(2):327-32.
PMID: 11529851
Deletions of 13q14.3 are well known in several malignancies and are thought to be associated with tumour suppressor function. The RB-1 gene is a tumour suppressor gene, but other loci...